About Us
Write for Us
Media Info
Advertising Info

Melatonin could help prevent growth of breast cancer tumors

Tuesday, February 25, 2014 by: L.J. Devon, Staff Writer
Tags: melatonin, breast cancer, prevention

Most Viewed Articles

(NaturalNews) New research from Henry Ford Hospital in Detroit suggests that breast cancer rates may be increasing due to lack of melatonin production in today's sleep deprived, light stimulated generation.

Melatonin, produced in the brain's pineal gland, is a hormone that plays a harmonic role in the body, modulating sleep patterns, circadian rhythms, and seasonal functions. Melatonin production is stimulated by darkness and inhibited by light. With all the gadgets, screens, and lights flashing in the eyes of people today, melatonin production can be restricted. Furthermore, the pineal gland is being calcified by environmental toxins like waste fluoride, which is intentionally added to many of today's water sources.

Known as the third eye, the pineal gland is about the size of a grain of rice and is located in the epithalamus, tucked in a groove between the two hemispheres near the center of the brain. As an endocrine gland, the third eye is responsible for producing melatonin. This process is easily obstructed today, since the pineal gland is becoming more calcified and hardened by fluoride. Televisions, handheld devices, and computer screens keep a steady flow of artificial light going into many people's eyes, keeping melatonin production down. A long list of pharmaceutical anti depressants, beta blockers, and blood pressure meds also bring down melatonin levels.

Research shows the importance for people to open their third eye

According to researchers from Detroit, melatonin production could help prevent the growth of breast cancer tumors, highlighting the importance of having a healthy, well functioning pineal gland.
Published online in the jounral PloS One, the study finds that melatonin can stop tumor growth and is capable of blocking the formation of new blood vessels in ER-negative breast cancer models.

Co-author Adarsh Shankar was astounded by the study, "These early stage research results with the melatonin drug in a triple-negative breast cancer animal models achieved in our lab has not been seen anywhere else. He continues, "The key finding of the study is that we now know that we can trace this drug and its effect on tumor growth, which opens the door for more research on this topic."

This research may lead us to discover that constant light stimulation from computers and handheld devices keep the brain from producing melatonin - in turn, increasing the risk of certain cancers.

Individuals wanting to open their third eye will seek to shift away from light emitting devices, allowing melatonin production to return in them while they also find ways to detoxify their pineal gland. This will definitely include filtration of fluoride from drinking water.

Melatonin production inhibits breast cancer growth, study

The Detroit researchers put melatonin to the test against ER-negative breast cancer in vitro and evaluated the hormone's effect on angiogenesis, the formation of new blood vessels.

For 21 nights melatonin was administered to a group of mice implanted with human breast cancer cells. The pharmacological melatonin was delivered one hour before dark as the tissues are more sensitive to the hormone's effects at this time.

Using single photon emission computed tomography, the researchers evaluated the size of the human breast cancer tissue in the mice each week. The analysis was completed after twenty one nights.

The melatonin treated mice didn't lose any weight and showed excessive energy and movement, with no signs of irritability or aggressive behavior, compared to the control group.

In the control group, given no melatonin, tumor volume increased significantly as the formation of new blood vessels grew the cancer. The melatonin group showed no angiogenesis.

In human cell models the results were replicated, showing that melatonin can reduce ER-negative breast cancer cell viability in vitro.

Antidepressants lower the level of melatonin the body, destroying a person's sleep pattern, circadian rhythm, and cancer prevention

One of the side effects of selective serotonin reuptake inhibitors is that these drugs can cause low levels of melatonin in humans. In fact, melatonin fights antidepressants. Studies show that melatonin conflicts with antidepressants desipramine and fluoxetine (Prozac), showing how these drugs wrack the human circadian rhythm, sleep pattern, and natural healing balance. Even beta blockers and blood pressure medications like methoxamine (Vasoxyl) and clonidine (Catopres) conflict with melatonin. These following calcium blocking pharmaceuticals have been found to hurt the pineal gland's natural production of melatonin as well: Nifedipine (Procardia),Amlodipine (Norvasc), Verapamil (Calan, Isoptin), Diltiazem (Cardizem), Felodipine (Plendil), Nisoldipine (Sular), Bepridil (Vascor).

This research shows the importance of the pineal gland, the production of melatonin, clean un-fluoridated drinking water, and independence from screens, antidepressants, and other melatonin blocking drugs.

Sources for this article include


Receive Our Free Email Newsletter

Get independent news alerts on natural cures, food lab tests, cannabis medicine, science, robotics, drones, privacy and more.

comments powered by Disqus

Natural News Wire (Sponsored Content)

Science News & Studies
Medicine News and Information
Food News & Studies
Health News & Studies
Herbs News & Information
Pollution News & Studies
Cancer News & Studies
Climate News & Studies
Survival News & Information
Gear News & Information
News covering technology, stocks, hackers, and more